Top Markets
Coin of the day
Immage Biotherapeutics Corp. Immage Biotherapeutics Corp.

Immage Biotherapeutics Corp.

IMMG
Rank in Stocks #41597
Presently, Immage Biotherapeutics Corp. lacks substantial business operations.... Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015. Its corporate headquarters are situated in Bethesda, Maryland, and it operates as a subsidiary of Coventry International Limited.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$15.17K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Immage Biotherapeutics Corp. (IMMG)
Revenue for Immage Biotherapeutics Corp. (IMMG)
Revenue in Aug 2026 TTM: 0
According to Immage Biotherapeutics Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Immage Biotherapeutics Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors